Usporedite metode

	Modificirani rani upozoravajući rezultat	CURB-65 ljestvica težine pneumonije	qSOFA bodovanje
Područje	Klinička procjena	Klinička procjena	Klinička procjena
Obitelj	Process / pipeline	Process / pipeline	Process / pipeline
Godina nastanka	2001	2003	2016
Tvorac	Christian P. Subbe, et al.	W. Staniford Lim, et al.	Sepsis-3 Taskforce
Vrsta	Hospital ward deterioration warning system	Community-acquired pneumonia severity assessment	Rapid sepsis screening
Temeljni izvor	Subbe, C. P., Kruger, M., Rutherford, P., & Gemmel, L. (2001). Validation of a modified Early Warning Score in medical admissions. QJM: An International Journal of Medicine, 94(10), 521-526.	Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Drugi nazivi	MEWS, Early warning score	CURB-65, Pneumonia severity	Quick SOFA, qSOFA
Srodne	3	3	3
Sažetak	The Modified Early Warning Score (MEWS), introduced by Subbe et al. in 2001, is a 14-point alert system designed for rapid detection of clinical deterioration in hospitalized patients. It combines six vital sign and laboratory parameters to identify patients at high risk of rapid decline, enabling early intervention before critical events occur.	CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.